[WATRMC 2018] How can delivery affect the efficiency and effectiveness of an advanced therapy?

In this interview, filmed at the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK), Biju Parekkadan, Co-founder, Sentien Biotechnologies, discusses the importance of considering drug delivery in advanced therapy development.

Go to the profile of RegMedNet
May 17, 2018
0
0
Upvote 0 Comment

As part of the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK) Interview Zone, RegMedNet Editor Freya Leask spoke to Biju Parekkadan, Co-founder, Sentien Biotechnologies (MA, USA). In this interview, Biju discusses why it’s important to consider the delivery method of a cell therapy in development and why we should be talking about bioethics.

Find out more about the World Advanced Therapies and Regenerative Medicine Congress on their website.

Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.